Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy

This study retrospectively investigated asparaginase-based chemotherapy treatment outcomes with or without radiotherapy in 143 patients with stage I(E)–II(E) extranodal natural killer/T cell lymphoma (ENKTCL). All patients received a median of three cycles of asparaginase-based chemotherapy, while 1...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Li, Yi-Yang, Feng, Ling-Ling, Niu, Shao-Qing, Wang, Han-Yu, Zhang, Lu-Lu, Wang, Liang, Xia, Zhong-Jun, Huang, Hui-Qiang, Xia, Yun-Fei, Zhang, Yu-Jing, Wang, Xi-Cheng
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355279/
https://ncbi.nlm.nih.gov/pubmed/28002792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak